Multicenter Study on the Pathogenic Germline Gene Variants of Colorectal Polyposis in China
NCT ID: NCT04961125
Last Updated: 2021-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2021-08-02
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Characteristics of Nonpolypoid Colorectal Neoplasms - A Chinese Cohort Study
NCT01533311
Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry
NCT05653960
High-Risk Factors in Patients With Colorectal Polyps a Prospective Case-Control Study
NCT04684134
A Population-based, Multicenter Cohort Study of Combined Screening for Gastrointestinal Tumors
NCT05996458
Research on Endoscopic Precision Biopsy.
NCT05261932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
colorectal polyposis
germline variants
Variants of 139 genes associated with different hereditary cancers and polyposis were screened by next-generation sequencing.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
germline variants
Variants of 139 genes associated with different hereditary cancers and polyposis were screened by next-generation sequencing.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. enough samples (provide at least 5ml of peripheral whole blood) for germline variant detection
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Hospital of Air Force
Beijing, Beijing Municipality, China
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Jiangsu Province Hospital
Nanjing, Jiangsu, China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
SAHZU
Hangzhou, Zhejinag, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Guoli Gu, MD
Role: primary
Daici Chen, PhD
Role: primary
Yanhong Gu, MD
Role: primary
Haixing Ju, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-072
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.